Skip to main content
. Author manuscript; available in PMC: 2014 Oct 24.
Published in final edited form as: Chem Res Toxicol. 2009 Mar 16;22(3):433–445. doi: 10.1021/tx8002752

Table 4.

Select Gene Expression Changes Mediated by BHa

Gene
Symbol
Description Fold Change MGI
Gene ID
6 h 24 h
Interferon-
associated
Signaling or
Regulation
H2-Ab1 histocompatibility 2, class II antigen
A, beta 1
−1.8 103070
H2-Q1 histocompatibility 2, Q region locus −4.8 95928
Immune
Response
Ccl2 chemokine (C-C motif) ligand 2 2.2 98259
Ccl6 chemokine (C-C motif) ligand 6 5.4 98263
Cd2 CD2 antigen 102.4 88320
Csf2 colony stimulating factor 2
(granulocyte-macrophage)
−12.1 1339752
Cxcl2 chemokine (C-X-C motif) ligand 2 1.9 1340094
Ereg epiregulin 13.2 107508
Fos FBJ osteosarcoma oncogene −3.6 95574
Il1a interleukin 1 alpha 6.0 96542
Il20 interleukin 20 2.4 1890473
Oxidative Stress
Response
Hmox1 heme oxygenase (decycling) 1 6.0 96163
Cell Structure Pstpip2 proline-serine-threonine
phosphatase interacting protein 2
6.1 1335088
Tuba4 tubulin, alpha 4 1.9 1095410
a

Genes altered ≥1.8-fold (p ≤ 0.01) up or down in LPS stimulated BH-treated cells relative to LPS stimulated cells. Fold changes (FC) represent the average of three independent biological experiments.